Regel Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Regel Therapeutics's estimated annual revenue is currently $2.7M per year.
- Regel Therapeutics's estimated revenue per employee is $77,500
- Regel Therapeutics's total funding is $5M.
Employee Data
- Regel Therapeutics has 35 Employees.
- Regel Therapeutics grew their employee count by 6% last year.
Regel Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & Chief Operating Officer | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | VP Research | Reveal Email/Phone |
4 | Program Director | Reveal Email/Phone |
5 | Program Director, In Vivo Preclinical Programs | Reveal Email/Phone |
6 | Senior Operations Manager | Reveal Email/Phone |
7 | Operations Manager | Reveal Email/Phone |
8 | Senior Scientist II | Reveal Email/Phone |
9 | Associate Scientist | Reveal Email/Phone |
10 | Senior Associate Scientist | Reveal Email/Phone |
Regel Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Regel Therapeutics?
Combining cutting edge science, experienced business leaders and innovators, Regel Therapeutics is committed to leveraging its proprietary platform technology to revolutionize gene therapy and change patient outcomes across multiple indications.
keywords:N/A$5M
Total Funding
35
Number of Employees
$2.7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.1M | 35 | 13% | N/A |
#2 | $8.6M | 35 | N/A | N/A |
#3 | $7M | 35 | N/A | N/A |
#4 | $3.9M | 35 | -36% | $50M |
#5 | $6M | 35 | 0% | N/A |